Combined Immune Checkpoint Blockade Enhances Antiviral Immunity against Bovine Leukemia Virus
Bovine leukemia virus (BLV) is a retrovirus that causes enzootic bovine leukosis (EBL) in cattle and is widespread in many countries, including Japan. Recent studies have revealed that the expression of immunoinhibitory molecules, such as programmed death-1 (PD-1) and PD-ligand 1, plays a critical r...
Saved in:
| Published in: | Journal of virology Vol. 97; no. 1; p. e0143022 |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
American Society for Microbiology
31-01-2023
|
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Bovine leukemia virus (BLV) is a retrovirus that causes enzootic bovine leukosis (EBL) in cattle and is widespread in many countries, including Japan. Recent studies have revealed that the expression of immunoinhibitory molecules, such as programmed death-1 (PD-1) and PD-ligand 1, plays a critical role in immunosuppression and disease progression during BLV infection. In addition, a preliminary study has suggested that another immunoinhibitory molecule, T-cell immunoglobulin domain and mucin domain-3 (TIM-3), is involved in immunosuppression during BLV infection. Therefore, this study was designed to further elucidate the immunoinhibitory role of immune checkpoint molecules in BLV infection. TIM-3 expression was upregulated on peripheral CD4
and CD8
T cells in BLV-infected cattle. Interestingly, in EBL cattle, CD4
and CD8
T cells infiltrating lymphomas expressed TIM-3. TIM-3 and PD-1 were upregulated and coexpressed in peripheral CD4
and CD8
T cells from BLV-infected cattle. Blockade by anti-bovine TIM-3 monoclonal antibody increased CD69 expression on T cells and gamma interferon (IFN-γ) production from peripheral blood mononuclear cells from BLV-infected cattle. A syncytium formation assay also demonstrated the antiviral effects of TIM-3 blockade against BLV infection. The combined inhibition of TIM-3 and PD-1 pathways significantly enhanced IFN-γ production and antiviral efficacy compared to inhibition alone. In conclusion, the combined blockade of TIM-3 and PD-1 pathways shows strong immune activation and antiviral effects and has potential as a novel therapeutic method for BLV infection.
Enzootic bovine leukosis caused by bovine leukemia virus (BLV) is an important viral disease in cattle, causing severe economic losses to the cattle industry worldwide. The molecular mechanisms of BLV-host interactions are complex. Previously, it was found that immune checkpoint molecules, such as PD-1, suppress BLV-specific Th1 responses as the disease progresses. To date, most studies have focused only on how PD-1 facilitates escape from host immunity in BLV-infected cattle and the antiviral effects of the PD-1 blockade. In contrast, how T-cell immunoglobulin domain and mucin domain-3 (TIM-3), another immune checkpoint molecule, regulates anti-BLV immune responses is rarely reported. It is also unclear why PD-1 inhibition alone was insufficient to exert anti-BLV effects in previous clinical studies. In this study, the expression profile of TIM-3 in T cells derived from BLV-infected cattle suggested that TIM-3 upregulation is a cause of immunosuppression in infected cattle. Based on these results, anti-TIM-3 antibody was used to experimentally evaluate its function in influencing immunity against BLV. Results indicated that TIM-3 upregulation induced by BLV infection suppressed T-cell activation and antiviral cytokine production. Some T cells coexpressed PD-1 and TIM-3, indicating that simultaneous inhibition of PD-1 and TIM-3 with their respective antibodies synergistically restored antiviral immunity. This study could open new avenues for treating bovine chronic infections. |
|---|---|
| AbstractList | Bovine leukemia virus (BLV) is a retrovirus that causes enzootic bovine leukosis (EBL) in cattle and is widespread in many countries, including Japan. Recent studies have revealed that the expression of immunoinhibitory molecules, such as programmed death-1 (PD-1) and PD-ligand 1, plays a critical role in immunosuppression and disease progression during BLV infection. In addition, a preliminary study has suggested that another immunoinhibitory molecule, T-cell immunoglobulin domain and mucin domain-3 (TIM-3), is involved in immunosuppression during BLV infection. Therefore, this study was designed to further elucidate the immunoinhibitory role of immune checkpoint molecules in BLV infection. TIM-3 expression was upregulated on peripheral CD4
and CD8
T cells in BLV-infected cattle. Interestingly, in EBL cattle, CD4
and CD8
T cells infiltrating lymphomas expressed TIM-3. TIM-3 and PD-1 were upregulated and coexpressed in peripheral CD4
and CD8
T cells from BLV-infected cattle. Blockade by anti-bovine TIM-3 monoclonal antibody increased CD69 expression on T cells and gamma interferon (IFN-γ) production from peripheral blood mononuclear cells from BLV-infected cattle. A syncytium formation assay also demonstrated the antiviral effects of TIM-3 blockade against BLV infection. The combined inhibition of TIM-3 and PD-1 pathways significantly enhanced IFN-γ production and antiviral efficacy compared to inhibition alone. In conclusion, the combined blockade of TIM-3 and PD-1 pathways shows strong immune activation and antiviral effects and has potential as a novel therapeutic method for BLV infection.
Enzootic bovine leukosis caused by bovine leukemia virus (BLV) is an important viral disease in cattle, causing severe economic losses to the cattle industry worldwide. The molecular mechanisms of BLV-host interactions are complex. Previously, it was found that immune checkpoint molecules, such as PD-1, suppress BLV-specific Th1 responses as the disease progresses. To date, most studies have focused only on how PD-1 facilitates escape from host immunity in BLV-infected cattle and the antiviral effects of the PD-1 blockade. In contrast, how T-cell immunoglobulin domain and mucin domain-3 (TIM-3), another immune checkpoint molecule, regulates anti-BLV immune responses is rarely reported. It is also unclear why PD-1 inhibition alone was insufficient to exert anti-BLV effects in previous clinical studies. In this study, the expression profile of TIM-3 in T cells derived from BLV-infected cattle suggested that TIM-3 upregulation is a cause of immunosuppression in infected cattle. Based on these results, anti-TIM-3 antibody was used to experimentally evaluate its function in influencing immunity against BLV. Results indicated that TIM-3 upregulation induced by BLV infection suppressed T-cell activation and antiviral cytokine production. Some T cells coexpressed PD-1 and TIM-3, indicating that simultaneous inhibition of PD-1 and TIM-3 with their respective antibodies synergistically restored antiviral immunity. This study could open new avenues for treating bovine chronic infections. Enzootic bovine leukosis caused by bovine leukemia virus (BLV) is an important viral disease in cattle, causing severe economic losses to the cattle industry worldwide. The molecular mechanisms of BLV-host interactions are complex. Bovine leukemia virus (BLV) is a retrovirus that causes enzootic bovine leukosis (EBL) in cattle and is widespread in many countries, including Japan. Recent studies have revealed that the expression of immunoinhibitory molecules, such as programmed death-1 (PD-1) and PD-ligand 1, plays a critical role in immunosuppression and disease progression during BLV infection. In addition, a preliminary study has suggested that another immunoinhibitory molecule, T-cell immunoglobulin domain and mucin domain-3 (TIM-3), is involved in immunosuppression during BLV infection. Therefore, this study was designed to further elucidate the immunoinhibitory role of immune checkpoint molecules in BLV infection. TIM-3 expression was upregulated on peripheral CD4 + and CD8 + T cells in BLV-infected cattle. Interestingly, in EBL cattle, CD4 + and CD8 + T cells infiltrating lymphomas expressed TIM-3. TIM-3 and PD-1 were upregulated and coexpressed in peripheral CD4 + and CD8 + T cells from BLV-infected cattle. Blockade by anti-bovine TIM-3 monoclonal antibody increased CD69 expression on T cells and gamma interferon (IFN-γ) production from peripheral blood mononuclear cells from BLV-infected cattle. A syncytium formation assay also demonstrated the antiviral effects of TIM-3 blockade against BLV infection. The combined inhibition of TIM-3 and PD-1 pathways significantly enhanced IFN-γ production and antiviral efficacy compared to inhibition alone. In conclusion, the combined blockade of TIM-3 and PD-1 pathways shows strong immune activation and antiviral effects and has potential as a novel therapeutic method for BLV infection. IMPORTANCE Enzootic bovine leukosis caused by bovine leukemia virus (BLV) is an important viral disease in cattle, causing severe economic losses to the cattle industry worldwide. The molecular mechanisms of BLV-host interactions are complex. Previously, it was found that immune checkpoint molecules, such as PD-1, suppress BLV-specific Th1 responses as the disease progresses. To date, most studies have focused only on how PD-1 facilitates escape from host immunity in BLV-infected cattle and the antiviral effects of the PD-1 blockade. In contrast, how T-cell immunoglobulin domain and mucin domain-3 (TIM-3), another immune checkpoint molecule, regulates anti-BLV immune responses is rarely reported. It is also unclear why PD-1 inhibition alone was insufficient to exert anti-BLV effects in previous clinical studies. In this study, the expression profile of TIM-3 in T cells derived from BLV-infected cattle suggested that TIM-3 upregulation is a cause of immunosuppression in infected cattle. Based on these results, anti-TIM-3 antibody was used to experimentally evaluate its function in influencing immunity against BLV. Results indicated that TIM-3 upregulation induced by BLV infection suppressed T-cell activation and antiviral cytokine production. Some T cells coexpressed PD-1 and TIM-3, indicating that simultaneous inhibition of PD-1 and TIM-3 with their respective antibodies synergistically restored antiviral immunity. This study could open new avenues for treating bovine chronic infections. Bovine leukemia virus (BLV) is a retrovirus that causes enzootic bovine leukosis (EBL) in cattle and is widespread in many countries, including Japan. Recent studies have revealed that the expression of immunoinhibitory molecules, such as programmed death-1 (PD-1) and PD-ligand 1, plays a critical role in immunosuppression and disease progression during BLV infection. In addition, a preliminary study has suggested that another immunoinhibitory molecule, T-cell immunoglobulin domain and mucin domain-3 (TIM-3), is involved in immunosuppression during BLV infection. Therefore, this study was designed to further elucidate the immunoinhibitory role of immune checkpoint molecules in BLV infection. TIM-3 expression was upregulated on peripheral CD4 + and CD8 + T cells in BLV-infected cattle. Interestingly, in EBL cattle, CD4 + and CD8 + T cells infiltrating lymphomas expressed TIM-3. TIM-3 and PD-1 were upregulated and coexpressed in peripheral CD4 + and CD8 + T cells from BLV-infected cattle. Blockade by anti-bovine TIM-3 monoclonal antibody increased CD69 expression on T cells and gamma interferon (IFN-γ) production from peripheral blood mononuclear cells from BLV-infected cattle. A syncytium formation assay also demonstrated the antiviral effects of TIM-3 blockade against BLV infection. The combined inhibition of TIM-3 and PD-1 pathways significantly enhanced IFN-γ production and antiviral efficacy compared to inhibition alone. In conclusion, the combined blockade of TIM-3 and PD-1 pathways shows strong immune activation and antiviral effects and has potential as a novel therapeutic method for BLV infection. IMPORTANCE Enzootic bovine leukosis caused by bovine leukemia virus (BLV) is an important viral disease in cattle, causing severe economic losses to the cattle industry worldwide. The molecular mechanisms of BLV-host interactions are complex. Previously, it was found that immune checkpoint molecules, such as PD-1, suppress BLV-specific Th1 responses as the disease progresses. To date, most studies have focused only on how PD-1 facilitates escape from host immunity in BLV-infected cattle and the antiviral effects of the PD-1 blockade. In contrast, how T-cell immunoglobulin domain and mucin domain-3 (TIM-3), another immune checkpoint molecule, regulates anti-BLV immune responses is rarely reported. It is also unclear why PD-1 inhibition alone was insufficient to exert anti-BLV effects in previous clinical studies. In this study, the expression profile of TIM-3 in T cells derived from BLV-infected cattle suggested that TIM-3 upregulation is a cause of immunosuppression in infected cattle. Based on these results, anti-TIM-3 antibody was used to experimentally evaluate its function in influencing immunity against BLV. Results indicated that TIM-3 upregulation induced by BLV infection suppressed T-cell activation and antiviral cytokine production. Some T cells coexpressed PD-1 and TIM-3, indicating that simultaneous inhibition of PD-1 and TIM-3 with their respective antibodies synergistically restored antiviral immunity. This study could open new avenues for treating bovine chronic infections. Bovine leukemia virus (BLV) is a retrovirus that causes enzootic bovine leukosis (EBL) in cattle and is widespread in many countries, including Japan. Recent studies have revealed that the expression of immunoinhibitory molecules, such as programmed death-1 (PD-1) and PD-ligand 1, plays a critical role in immunosuppression and disease progression during BLV infection. In addition, a preliminary study has suggested that another immunoinhibitory molecule, T-cell immunoglobulin domain and mucin domain-3 (TIM-3), is involved in immunosuppression during BLV infection. Therefore, this study was designed to further elucidate the immunoinhibitory role of immune checkpoint molecules in BLV infection. TIM-3 expression was upregulated on peripheral CD4+ and CD8+ T cells in BLV-infected cattle. Interestingly, in EBL cattle, CD4+ and CD8+ T cells infiltrating lymphomas expressed TIM-3. TIM-3 and PD-1 were upregulated and coexpressed in peripheral CD4+ and CD8+ T cells from BLV-infected cattle. Blockade by anti-bovine TIM-3 monoclonal antibody increased CD69 expression on T cells and gamma interferon (IFN-γ) production from peripheral blood mononuclear cells from BLV-infected cattle. A syncytium formation assay also demonstrated the antiviral effects of TIM-3 blockade against BLV infection. The combined inhibition of TIM-3 and PD-1 pathways significantly enhanced IFN-γ production and antiviral efficacy compared to inhibition alone. In conclusion, the combined blockade of TIM-3 and PD-1 pathways shows strong immune activation and antiviral effects and has potential as a novel therapeutic method for BLV infection. IMPORTANCE Enzootic bovine leukosis caused by bovine leukemia virus (BLV) is an important viral disease in cattle, causing severe economic losses to the cattle industry worldwide. The molecular mechanisms of BLV-host interactions are complex. Previously, it was found that immune checkpoint molecules, such as PD-1, suppress BLV-specific Th1 responses as the disease progresses. To date, most studies have focused only on how PD-1 facilitates escape from host immunity in BLV-infected cattle and the antiviral effects of the PD-1 blockade. In contrast, how T-cell immunoglobulin domain and mucin domain-3 (TIM-3), another immune checkpoint molecule, regulates anti-BLV immune responses is rarely reported. It is also unclear why PD-1 inhibition alone was insufficient to exert anti-BLV effects in previous clinical studies. In this study, the expression profile of TIM-3 in T cells derived from BLV-infected cattle suggested that TIM-3 upregulation is a cause of immunosuppression in infected cattle. Based on these results, anti-TIM-3 antibody was used to experimentally evaluate its function in influencing immunity against BLV. Results indicated that TIM-3 upregulation induced by BLV infection suppressed T-cell activation and antiviral cytokine production. Some T cells coexpressed PD-1 and TIM-3, indicating that simultaneous inhibition of PD-1 and TIM-3 with their respective antibodies synergistically restored antiviral immunity. This study could open new avenues for treating bovine chronic infections. |
| Author | Nakamura, Hayato Murata, Shiro Kato, Yukinari Ohashi, Kazuhiko Watari, Kei Saito, Maya Sajiki, Yamato Kamitani, Kana Suzuki, Yasuhiko Okagawa, Tomohiro Maekawa, Naoya Konnai, Satoru |
| Author_xml | – sequence: 1 givenname: Hayato surname: Nakamura fullname: Nakamura, Hayato organization: Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan – sequence: 2 givenname: Satoru orcidid: 0000-0002-3230-7109 surname: Konnai fullname: Konnai, Satoru organization: Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan – sequence: 3 givenname: Tomohiro surname: Okagawa fullname: Okagawa, Tomohiro organization: Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan – sequence: 4 givenname: Naoya surname: Maekawa fullname: Maekawa, Naoya organization: Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan – sequence: 5 givenname: Yamato surname: Sajiki fullname: Sajiki, Yamato organization: Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan – sequence: 6 givenname: Kei surname: Watari fullname: Watari, Kei organization: Department of Disease Control, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan – sequence: 7 givenname: Kana surname: Kamitani fullname: Kamitani, Kana organization: Hokkaido Hayakita Meat Inspection Center, Hokkaido Government, Abira, Japan – sequence: 8 givenname: Maya surname: Saito fullname: Saito, Maya organization: Hokkaido Hayakita Meat Inspection Center, Hokkaido Government, Abira, Japan – sequence: 9 givenname: Yukinari surname: Kato fullname: Kato, Yukinari organization: Department of Molecular Pharmacology, Tohoku University Graduate School of Medicine, Sendai, Japan – sequence: 10 givenname: Yasuhiko surname: Suzuki fullname: Suzuki, Yasuhiko organization: Division of Bioresources, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan – sequence: 11 givenname: Shiro surname: Murata fullname: Murata, Shiro organization: Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan – sequence: 12 givenname: Kazuhiko surname: Ohashi fullname: Ohashi, Kazuhiko organization: Department of Advanced Pharmaceutics, Faculty of Veterinary Medicine, Hokkaido University, Sapporo, Japan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36598199$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kc9LwzAUx4Mo7ofePEuvgp1J2qbJRZhl6mDgRcWLhCRNt2xrMpq2sP_eanXowdM7vM_78t7njcCxdVYDcIHgBCFMb9atmUAURzDE-AgMEWQ0TBIUH4MhhBiHSUTfBmDk_Rp2WEziUzCISMIoYmwI3jNXSmN1HszLsrE6yFZabXbO2Dq42zq1EbkOZnYlrNI-mNratKYS25429T4QS2Gs72DXdjHBQjcbXRoRvJqq8WfgpBBbr8-_6xi83M-es8dw8fQwz6aLUCSY1qGiRKZEUqI0gUUU5UTqnDBCSEqZSBQplEhkKqVilBHGNCsoZjiHBKVYSxiNwW2fu2tkqXOlbd0tyXeVKUW1504Y_rdjzYovXcsZpRR38sbgug9QlfO-0sVhFkH-qZl3mvmXZo5xh1_1uPAl5mvXVLY77z_28vduh-CfH0Qf8sSKRA |
| CitedBy_id | crossref_primary_10_1186_s12917_024_03977_1 crossref_primary_10_1016_j_vetimm_2023_110609 |
| Cites_doi | 10.4049/jimmunol.1900342 10.1292/jvms.63.703 10.3389/fimmu.2017.00650 10.1128/JVI.68.7.4589-4596.1994 10.1128/IAI.01014-15 10.1016/j.cimid.2012.09.005 10.1016/j.jhep.2009.12.005 10.1038/ni.2035 10.1292/jvms.16-0354 10.1016/j.vetimm.2014.10.006 10.1093/infdis/jiq153 10.1038/s41577-019-0224-6 10.1016/j.dci.2020.103847 10.1172/JCI43127 10.1371/journal.pone.0009504 10.1073/pnas.82.3.677 10.1128/JVI.70.4.2178-2183.1996 10.4049/immunohorizons.2000089 10.3389/fvets.2020.00012 10.1016/s0378-1135(03)00119-6 10.1172/JCI45138 10.4161/onci.23849 10.1016/j.vetimm.2011.08.018 10.1186/s12917-019-2082-7 10.1038/nri3790 10.3892/ol.2018.8835 10.1056/NEJMoa1200690 10.1128/JVI.72.8.6917-6921.1998 10.1371/journal.pone.0174916 10.1038/ni987 10.1073/pnas.1009731107 10.1186/1742-4690-4-18 10.1128/iai.00210-22 10.1038/ni988 10.1128/JVI.70.8.5706-5710.1996 10.1002/eji.200939274 10.1038/ni.1679 10.1292/jvms.20-0590 10.1016/j.it.2013.10.001 10.1038/nm.2871 10.1128/IAI.00910-17 10.1007/s00345-015-1656-7 10.1111/j.1348-0421.2010.00208.x 10.1056/NEJMoa1305133 10.1038/nri1111 10.1371/journal.pntd.0001030 10.1016/j.immuni.2007.01.016 10.1128/JVI.00639-09 10.1186/s12967-019-1917-0 10.1084/jem.20081398 10.1038/ni.2376 10.1186/1297-9716-42-103 10.1084/jem.20100643 10.1038/415536a 10.1084/jem.20100637 10.1002/iid3.93 10.1038/ni1271 10.1038/nature13848 10.1186/s13567-018-0543-9 10.1038/ncomms10501 10.1186/1297-9716-44-59 10.1128/IAI.00278-16 10.1080/2162402X.2016.1261779 10.1126/science.1148536 10.1186/1297-9716-43-45 10.14943/jjvr.68.2.77 |
| ContentType | Journal Article |
| Copyright | Copyright © 2023 American Society for Microbiology. Copyright © 2023 American Society for Microbiology. 2023 American Society for Microbiology |
| Copyright_xml | – notice: Copyright © 2023 American Society for Microbiology. – notice: Copyright © 2023 American Society for Microbiology. 2023 American Society for Microbiology |
| DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
| DOI | 10.1128/jvi.01430-22 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
| DatabaseTitleList | MEDLINE CrossRef |
| Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1098-5514 |
| Editor | Kirchhoff, Frank |
| Editor_xml | – sequence: 1 givenname: Frank surname: Kirchhoff fullname: Kirchhoff, Frank |
| ExternalDocumentID | 10_1128_jvi_01430_22 01430-22 36598199 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: MEXT | Japan Society for the Promotion of Science (JSPS) grantid: 22K19232 funderid: https://doi.org/10.13039/501100001691 – fundername: National Agriculture and Food Research Organization (NARO) grantid: 26058 BC funderid: https://doi.org/10.13039/501100007172 – fundername: Japan Agency for Medical Research and Development (AMED) grantid: JP223fa627005 funderid: https://doi.org/10.13039/100009619 – fundername: National Agriculture and Food Research Organization (NARO) grantid: 16817557 funderid: https://doi.org/10.13039/501100007172 – fundername: Japan Agency for Medical Research and Development (AMED) grantid: JP21am0101078 funderid: https://doi.org/10.13039/100009619 – fundername: Ministry of Agriculture, Forestry and Fisheries (MAFF) grantid: JPJ008617.17935709 funderid: https://doi.org/10.13039/501100003993 – fundername: MEXT | Japan Society for the Promotion of Science (JSPS) grantid: 19KK0172 funderid: https://doi.org/10.13039/501100001691 – fundername: MEXT | Japan Society for the Promotion of Science (JSPS) grantid: 22H02503 funderid: https://doi.org/10.13039/501100001691 – fundername: Japan Agency for Medical Research and Development (AMED) grantid: JP22ama121008 funderid: https://doi.org/10.13039/100009619 – fundername: ; grantid: 26058 BC – fundername: ; grantid: JPJ008617.17935709 – fundername: ; grantid: 19KK0172 – fundername: ; grantid: JP223fa627005 – fundername: ; grantid: 22H02503 – fundername: ; grantid: 16817557 – fundername: ; grantid: 22K19232 – fundername: ; grantid: JP21am0101078 – fundername: ; grantid: JP22ama121008 |
| GroupedDBID | --- -~X 0R~ 18M 29L 2WC 39C 4.4 53G 5GY 5RE 5VS 85S ABPPZ ACGFO ACNCT ADBBV AENEX AGVNZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BTFSW CGR CS3 CUY CVF DIK E3Z EBS ECM EIF F5P FRP GX1 H13 HYE HZ~ IH2 KQ8 N9A NPM O9- OK1 P2P RHF RHI RNS RPM RSF TR2 UCJ UPT W2D W8F WH7 WOQ YQT ~02 ~KM 8W4 ABFLS ABPTK ZA5 AAYXX CITATION 5PM |
| ID | FETCH-LOGICAL-a528t-c86b76b86ce60f33d6bed69666789a5c6fca5b7bbc989699e9f8292d06172eb03 |
| IEDL.DBID | RPM |
| ISSN | 0022-538X |
| IngestDate | Tue Sep 17 21:30:35 EDT 2024 Thu Nov 21 21:14:15 EST 2024 Tue Jan 31 21:35:08 EST 2023 Sat Sep 28 08:16:42 EDT 2024 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | PD-L1 cattle TIM-3 bovine leukemia virus lymphoma |
| Language | English |
| License | All Rights Reserved. https://doi.org/10.1128/ASMCopyrightv2 All Rights Reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-a528t-c86b76b86ce60f33d6bed69666789a5c6fca5b7bbc989699e9f8292d06172eb03 |
| Notes | The authors declare no conflict of interest. |
| ORCID | 0000-0002-3230-7109 |
| OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9888214 |
| PMID | 36598199 |
| PageCount | 16 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_9888214 crossref_primary_10_1128_jvi_01430_22 asm2_journals_10_1128_jvi_01430_22 pubmed_primary_36598199 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-01-31 |
| PublicationDateYYYYMMDD | 2023-01-31 |
| PublicationDate_xml | – month: 01 year: 2023 text: 2023-01-31 day: 31 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
| PublicationTitle | Journal of virology |
| PublicationTitleAbbrev | J Virol |
| PublicationTitleAlternate | J Virol |
| PublicationYear | 2023 |
| Publisher | American Society for Microbiology |
| Publisher_xml | – name: American Society for Microbiology |
| References | Chiba, S, Baghdadi, M, Akiba, H, Yoshiyama, H, Kinoshita, I, Dosaka-Akita, H, Fujioka, Y, Ohba, Y, Gorman, JV, Colgan, JD, Hirashima, M, Uede, T, Takaoka, A, Yagita, H, Jinushi, M (B11) 2012; 13 Ohira, K, Nakahara, A, Konnai, S, Okagawa, T, Nishimori, A, Maekawa, N, Ikebuchi, R, Kohara, J, Murata, S, Ohashi, K (B35) 2016; 4 Sajiki, Y, Konnai, S, Watari, K, Okagawa, T, Tanaka, A, Kawaji, S, Nagata, R, Maekawa, N, Suzuki, Y, Kato, Y, Murata, S, Mori, Y, Ohashi, K (B57) 2022; 90 Konnai, S, Murata, S, Ohashi, K (B39) 2017; 79 Wherry, EJ (B1) 2011; 12 Sakuishi, K, Ngiow, SF, Sullivan, JM, Teng, MW, Kuchroo, VK, Smyth, MJ, Anderson, AC (B59) 2013; 2 Okagawa, T, Konnai, S, Deringer, JR, Ueti, MW, Scoles, GA, Murata, S, Ohashi, K, Brown, WC (B54) 2016; 84 Sajiki, Y, Konnai, S, Cai, Z, Takada, K, Okagawa, T, Maekawa, N, Fujisawa, S, Kato, Y, Suzuki, Y, Murata, S, Ohashi, K (B65) 2020; 4 Pyeon, D, Splitter, GA (B33) 1998; 72 Jones, RB, Ndhlovu, LC, Barbour, JD, Sheth, PM, Jha, AR, Long, BR, Wong, JC, Satkunarajah, M, Schweneker, M, Chapman, JM, Gyenes, G, Vali, B, Hyrcza, MD, Yue, FY, Kovacs, C, Sassi, A, Loutfy, M, Halpenny, R, Persad, D, Spotts, G, Hecht, FM, Chun, TW, McCune, JM, Kaul, R, Rini, JM, Nixon, DF, Ostrowski, MA (B5) 2008; 205 Schwartz, I, Bensaid, A, Polack, B, Perrin, B, Berthelemy, M, Levy, D (B27) 1994; 68 Han, ZM, Huang, HM, Sun, YW (B17) 2018; 16 Suzuki, S, Konnai, S, Okagawa, T, Ikebuchi, R, Nishimori, A, Kohara, J, Mingala, CN, Murata, S, Ohashi, K (B46) 2015; 163 Zheng, Y, Li, Y, Lian, J, Yang, H, Li, F, Zhao, S, Qi, Y, Zhang, Y, Huang, L (B64) 2019; 17 Mengshol, JA, Golden-Mason, L, Arikawa, T, Smith, M, Niki, T, McWilliams, R, Randall, JA, McMahan, R, Zimmerman, MA, Rangachari, M, Dobrinskikh, E, Busson, P, Polyak, SJ, Hirashima, M, Rosen, HR (B22) 2010; 5 Gupta, S, Thornley, TB, Gao, W, Larocca, R, Turka, LA, Kuchroo, VK, Strom, TB (B58) 2012; 122 Okagawa, T, Konnai, S, Nishimori, A, Maekawa, N, Goto, S, Ikebuchi, R, Kohara, J, Suzuki, Y, Yamada, S, Kato, Y, Murata, S, Ohashi, K (B45) 2018; 49 Pyeon, D, O’Reilly, KL, Splitter, GA (B32) 1996; 70 Kabeya, H, Ohashi, K, Onuma, M (B30) 2001; 63 Huang, Y-H, Zhu, C, Kondo, Y, Anderson, AC, Gandhi, A, Russell, A, Dougan, SK, Petersen, B-S, Melum, E, Pertel, T, Clayton, KL, Raab, M, Chen, Q, Beauchemin, N, Yazaki, PJ, Pyzik, M, Ostrowski, MA, Glickman, JN, Rudd, CE, Ploegh, HL, Franke, A, Petsko, GA, Kuchroo, VK, Blumberg, RS (B12) 2015; 517 Goto, S, Konnai, S, Hirano, Y, Kohara, J, Okagawa, T, Maekawa, N, Sajiki, Y, Watari, K, Minato, E, Kobayashi, A, Gondaira, S, Higuchi, H, Koiwa, M, Tajima, M, Taguchi, E, Ishida, M, Uemura, R, Yamada, S, Kaneko, MK, Kato, Y, Yamamoto, K, Toda, M, Suzuki, Y, Murata, S, Ohashi, K (B56) 2020; 68 Ndhlovu, LC, Leal, FE, Hasenkrug, AM, Jha, AR, Carvalho, KI, Eccles-James, IG, Bruno, FR, Vieira, RG, York, VA, Chew, GM, Jones, RB, Tanaka, Y, Neto, WK, Sanabani, SS, Ostrowski, MA, Segurado, AC, Nixon, DF, Kallas, EG (B50) 2011; 5 Wolf, Y, Anderson, AC, Kuchroo, VK (B14) 2020; 20 Sajiki, Y, Konnai, S, Okagawa, T, Nishimori, A, Maekawa, N, Goto, S, Watari, K, Minato, E, Kobayashi, A, Kohara, J, Yamada, S, Kaneko, MK, Kato, Y, Takahashi, H, Terasaki, N, Takeda, A, Yamamoto, K, Toda, M, Suzuki, Y, Murata, S, Ohashi, K (B42) 2019; 203 Okagawa, T, Konnai, S, Nishimori, A, Maekawa, N, Ikebuchi, R, Goto, S, Nakajima, C, Kohara, J, Ogasawara, S, Kato, Y, Suzuki, Y, Murata, S, Ohashi, K (B41) 2017; 8 Schietinger, A, Greenberg, PD (B3) 2014; 35 Zhu, C, Anderson, AC, Schubart, A, Xiong, H, Imitola, J, Khoury, SJ, Zheng, XX, Strom, TB, Kuchroo, VK (B9) 2005; 6 Shayan, G, Srivastava, R, Li, J, Schmitt, N, Kane, LP, Ferris, RL (B63) 2017; 6 Sabatos, CA, Chakravarti, S, Cha, E, Schubart, A, Sánchez-Fueyo, A, Zheng, XX, Coyle, AJ, Strom, TB, Freeman, GJ, Kuchroo, VK (B15) 2003; 4 Gillet, N, Florins, A, Boxus, M, Burteau, C, Nigro, A, Vandermeers, F, Balon, H, Bouzar, AB, Defoiche, J, Burny, A, Reichert, M, Kettmann, R, Willems, L (B31) 2007; 4 Goto, S, Konnai, S, Hirano, Y, Kohara, J, Okagawa, T, Maekawa, N, Sajiki, Y, Watari, K, Minato, E, Kobayashi, A, Gondaira, S, Higuchi, H, Koiwa, M, Tajima, M, Taguchi, E, Uemura, R, Yamada, S, Kaneko, MK, Kato, Y, Yamamoto, K, Toda, M, Suzuki, Y, Murata, S, Ohashi, K (B55) 2020; 7 Jin, HT, Anderson, AC, Tan, WG, West, EE, Ha, SJ, Araki, K, Freeman, GJ, Kuchroo, VK, Ahmed, R (B19) 2010; 107 McMahan, RH, Golden-Mason, L, Nishimura, MI, McMahon, BJ, Kemper, M, Allen, TM, Gretch, DR, Rosen, HR (B21) 2010; 120 Abdelbary, NH, Abdullah, HM, Matsuzaki, T, Hayashi, D, Tanaka, Y, Takashima, H, Izumo, S, Kubota, R (B49) 2011; 203 Sánchez-Fueyo, A, Tian, J, Picarella, D, Domenig, C, Zheng, XX, Sabatos, CA, Manlongat, N, Bender, O, Kamradt, T, Kuchroo, VK, Gutiérrez-Ramos, JC, Coyle, AJ, Strom, TB (B18) 2003; 4 Schwartz, I, Levy, D (B29) 1994; 25 Ikebuchi, R, Konnai, S, Shirai, T, Sunden, Y, Murata, S, Onuma, M, Ohashi, K (B37) 2011; 42 Nishimori, A, Konnai, S, Okagawa, T, Maekawa, N, Ikebuchi, R, Goto, S, Sajiki, Y, Suzuki, Y, Kohara, J, Ogasawara, S, Kato, Y, Murata, S, Ohashi, K (B40) 2017; 12 Hastings, WD, Anderson, DE, Kassam, N, Koguchi, K, Greenfield, EA, Kent, SC, Zheng, XX, Strom, TB, Hafler, DA, Kuchroo, VK (B16) 2009; 39 Ju, Y, Hou, N, Meng, J, Wang, X, Zhang, X, Zhao, D, Liu, Y, Zhu, F, Zhang, L, Sun, W, Liang, X, Gao, L, Ma, C (B7) 2010; 52 Monney, L, Sabatos, CA, Gaglia, JL, Ryu, A, Waldner, H, Chernova, T, Manning, S, Greenfield, EA, Coyle, AJ, Sobel, RA, Freeman, GJ, Kuchroo, VK (B4) 2002; 415 Okagawa, T, Konnai, S, Ikebuchi, R, Suzuki, S, Shirai, T, Sunden, Y, Onuma, M, Murata, S, Ohashi, K (B48) 2012; 43 Sakuishi, K, Apetoh, L, Sullivan, JM, Blazar, BR, Kuchroo, VK, Anderson, AC (B24) 2010; 207 Konnai, S, Usui, T, Ohashi, K, Onuma, M (B34) 2003; 94 Sajiki, Y, Konnai, S, Okagawa, T, Maekawa, N, Nakamura, H, Kato, Y, Suzuki, Y, Murata, S, Ohashi, K (B67) 2021; 114 Watari, K, Konnai, S, Maekawa, N, Okagawa, T, Suzuki, Y, Murata, S, Ohashi, K (B47) 2019; 15 Rangachari, M, Zhu, C, Sakuishi, K, Xiao, S, Karman, J, Chen, A, Angin, M, Wakeham, A, Greenfield, EA, Sobel, RA, Okada, H, McKinnon, PJ, Mak, TW, Addo, MM, Anderson, AC, Kuchroo, VK (B13) 2012; 18 Kuchroo, VK, Umetsu, DT, DeKruyff, RH, Freeman, GJ (B8) 2003; 3 Koyama, S, Akbay, EA, Li, YY, Herter-Sprie, GS, Buczkowski, KA, Richards, WG, Gandhi, L, Redig, AJ, Rodig, SJ, Asahina, H, Jones, RE, Kulkarni, MM, Kuraguchi, M, Palakurthi, S, Fecci, PE, Johnson, BE, Janne, PA, Engelman, JA, Gangadharan, SP, Costa, DB, Freeman, GJ, Bueno, R, Hodi, FS, Dranoff, G, Wong, KK, Hammerman, PS (B62) 2016; 7 Mirsky, ML, Olmstead, CA, Da, Y, Lewin, HA (B28) 1996; 70 Sagata, N, Yasunaga, T, Tsuzuku-Kawamura, J, Ohishi, K, Ogawa, Y, Ikawa, Y (B26) 1985; 82 Hamid, O, Robert, C, Daud, A, Hodi, FS, Hwu, WJ, Kefford, R, Wolchok, JD, Hersey, P, Joseph, RW, Weber, JS, Dronca, R, Gangadhar, TC, Patnaik, A, Zarour, H, Joshua, AM, Gergich, K, Elassaiss-Schaap, J, Algazi, A, Mateus, C, Boasberg, P, Tumeh, PC, Chmielowski, B, Ebbinghaus, SW, Li, XN, Kang, SP, Ribas, A (B61) 2013; 369 Cao, E, Zang, X, Ramagopal, UA, Mukhopadhaya, A, Fedorov, A, Fedorov, E, Zencheck, WD, Lary, JW, Cole, JL, Deng, H, Xiao, H, Dilorenzo, TP, Allison, JP, Nathenson, SG, Almo, SC (B10) 2007; 26 Topalian, SL, Hodi, FS, Brahmer, JR, Gettinger, SN, Smith, DC, McDermott, DF, Powderly, JD, Carvajal, RD, Sosman, JA, Atkins, MB, Leming, PD, Spigel, DR, Antonia, SJ, Horn, L, Drake, CG, Pardoll, DM, Chen, L, Sharfman, WH, Anders, RA, Taube, JM, McMiller, TL, Xu, H, Korman, AJ, Jure-Kunkel, M, Agrawal, S, McDonald, D, Kollia, GD, Gupta, A, Wigginton, JM, Sznol, M (B60) 2012; 366 Anderson, AC, Anderson, DE, Bregoli, L, Hastings, WD, Kassam, N, Lei, C, Chandwaskar, R, Karman, J, Su, EW, Hirashima, M, Bruce, JN, Kane, LP, Kuchroo, VK, Hafler, DA (B6) 2007; 318 Cai, C, Xu, YF, Wu, ZJ, Dong, Q, Li, MY, Olson, JC, Rabinowitz, YM, Wang, LH, Sun, Y (B25) 2016; 34 Ikebuchi, R, Konnai, S, Sunden, Y, Onuma, M, Ohashi, K (B36) 2010; 54 Blackburn, SD, Shin, H, Haining, WN, Zou, T, Workman, CJ, Polley, A, Betts, MR, Freeman, GJ, Vignali, DAA, Wherry, EJ (B66) 2009; 10 Golden-Mason, L, Palmer, BE, Kassam, N, Townshend-Bulson, L, Livingston, S, McMahon, BJ, Castelblanco, N, Kuchroo, V, Gretch, DR, Rosen, HR (B20) 2009; 83 Sajiki, Y, Konnai, S, Okagawa, T, Nishimori, A, Maekawa, N, Goto, S, Ikebuchi, R, Nagata, R, Kawaji, S, Kagawa, Y, Yamada, S, Kato, Y, Nakajima, C, Suzuki, Y, Murata, S, Mori, Y, Ohashi, K (B52) 2018; 86 Sajiki, Y, Konnai, S, Nagata, R, Kawaji, S, Nakamura, H, Fujisawa, S, Okagawa, T, Maekawa, N, Kato, Y, Suzuki, Y, Murata, S, Mori, Y, Ohashi, K (B53) 2021; 83 Konnai, S, Suzuki, S, Shirai, T, Ikebuchi, R, Okagawa, T, Sunden, Y, Mingala, CN, Onuma, M, Murata, S, Ohashi, K (B44) 2013; 36 Fourcade, J, Sun, Z, Benallaoua, M, Guillaume, P, Luescher, IF, Sander, C, Kirkwood, JM, Kuchroo, V, Zarour, HM (B23) 2010; 207 Shirai, T, Konnai, S, Ikebuchi, R, Okagawa, T, Suzuki, S, Sunden, Y, Onuma, M, Murata, S, Ohashi, K (B43) 2011; 144 Okagawa, T, Konnai, S, Nishimori, A, Ikebuchi, R, Mizorogi, S, Nagata, R, Kawaji, S, Tanaka, S, Kagawa, Y, Murata, S, Mori, Y, Ohashi, K (B51) 2016; 84 Nguyen, LT, Ohashi, PS (B2) 2015; 15 Ikebuchi, R, Konnai, S, Okagawa, T, Yokoyama, K, Nakajima, C, Suzuki, Y, Murata, S, Ohashi, K (B38) 2013; 44 e_1_3_2_26_2 e_1_3_2_49_2 e_1_3_2_28_2 e_1_3_2_41_2 e_1_3_2_64_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_62_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_68_2 e_1_3_2_24_2 e_1_3_2_47_2 e_1_3_2_66_2 e_1_3_2_60_2 e_1_3_2_9_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_54_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_52_2 e_1_3_2_5_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_58_2 e_1_3_2_3_2 e_1_3_2_14_2 e_1_3_2_35_2 e_1_3_2_56_2 e_1_3_2_50_2 e_1_3_2_27_2 e_1_3_2_48_2 e_1_3_2_29_2 e_1_3_2_40_2 e_1_3_2_65_2 e_1_3_2_21_2 e_1_3_2_42_2 e_1_3_2_63_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_25_2 e_1_3_2_46_2 e_1_3_2_67_2 e_1_3_2_61_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_17_2 e_1_3_2_59_2 e_1_3_2_6_2 e_1_3_2_19_2 e_1_3_2_53_2 e_1_3_2_32_2 e_1_3_2_51_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_57_2 e_1_3_2_4_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_55_2 e_1_3_2_2_2 Schwartz I (e_1_3_2_30_2) 1994; 25 |
| References_xml | – volume: 203 start-page: 1313 year: 2019 end-page: 1324 ident: B42 article-title: Prostaglandin E2-induced immune exhaustion and enhancement of antiviral effects by anti-PD-L1 antibody combined with COX-2 inhibitor in bovine leukemia virus infection publication-title: J Immunol doi: 10.4049/jimmunol.1900342 contributor: fullname: Ohashi, K – volume: 63 start-page: 703 year: 2001 end-page: 708 ident: B30 article-title: Host immune responses in the course of bovine leukemia virus infection publication-title: J Vet Med Sci doi: 10.1292/jvms.63.703 contributor: fullname: Onuma, M – volume: 8 start-page: 650 year: 2017 ident: B41 article-title: Anti-bovine programmed death-1 rat-bovine chimeric antibody for immunotherapy of bovine leukemia virus infection in cattle publication-title: Front Immunol doi: 10.3389/fimmu.2017.00650 contributor: fullname: Ohashi, K – volume: 68 start-page: 4589 year: 1994 end-page: 4596 ident: B27 article-title: In vivo leukocyte tropism of bovine leukemia virus in sheep and cattle publication-title: J Virol doi: 10.1128/JVI.68.7.4589-4596.1994 contributor: fullname: Levy, D – volume: 84 start-page: 77 year: 2016 end-page: 89 ident: B51 article-title: Bovine immunoinhibitory receptors contribute to suppression of Mycobacterium avium subsp. paratuberculosis-specific T-cell responses publication-title: Infect Immun doi: 10.1128/IAI.01014-15 contributor: fullname: Ohashi, K – volume: 36 start-page: 63 year: 2013 end-page: 69 ident: B44 article-title: Enhanced expression of LAG-3 on lymphocyte subpopulations from persistently lymphocytotic cattle infected with bovine leukemia virus publication-title: Comp Immunol Microbiol Infect Dis doi: 10.1016/j.cimid.2012.09.005 contributor: fullname: Ohashi, K – volume: 52 start-page: 322 year: 2010 end-page: 329 ident: B7 article-title: T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B publication-title: J Hepatol doi: 10.1016/j.jhep.2009.12.005 contributor: fullname: Ma, C – volume: 12 start-page: 492 year: 2011 end-page: 499 ident: B1 article-title: T cell exhaustion publication-title: Nat Immunol doi: 10.1038/ni.2035 contributor: fullname: Wherry, EJ – volume: 79 start-page: 1 year: 2017 end-page: 5 ident: B39 article-title: Immune exhaustion during chronic infections in cattle publication-title: J Vet Med Sci doi: 10.1292/jvms.16-0354 contributor: fullname: Ohashi, K – volume: 163 start-page: 115 year: 2015 end-page: 124 ident: B46 article-title: Increased expression of the regulatory T cell-associated marker CTLA-4 in bovine leukemia virus infection publication-title: Vet Immunol Immunopathol doi: 10.1016/j.vetimm.2014.10.006 contributor: fullname: Ohashi, K – volume: 203 start-page: 948 year: 2011 end-page: 959 ident: B49 article-title: Reduced Tim-3 expression on human T-lymphotropic virus type I (HTLV-I) Tax-specific cytotoxic T lymphocytes in HTLV-I infection publication-title: J Infect Dis doi: 10.1093/infdis/jiq153 contributor: fullname: Kubota, R – volume: 20 start-page: 173 year: 2020 end-page: 185 ident: B14 article-title: TIM3 comes of age as an inhibitory receptor publication-title: Nat Rev Immunol doi: 10.1038/s41577-019-0224-6 contributor: fullname: Kuchroo, VK – volume: 114 start-page: 103847 year: 2021 ident: B67 article-title: A TLR7 agonist activates bovine Th1 response and exerts antiviral activity against bovine leukemia virus publication-title: Dev Comp Immunol doi: 10.1016/j.dci.2020.103847 contributor: fullname: Ohashi, K – volume: 120 start-page: 4546 year: 2010 end-page: 4557 ident: B21 article-title: Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity publication-title: J Clin Invest doi: 10.1172/JCI43127 contributor: fullname: Rosen, HR – volume: 5 year: 2010 ident: B22 article-title: A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection publication-title: PLoS One doi: 10.1371/journal.pone.0009504 contributor: fullname: Rosen, HR – volume: 82 start-page: 677 year: 1985 end-page: 681 ident: B26 article-title: Complete nucleotide sequence of the genome of bovine leukemia virus: its evolutionary relationship to other retroviruses publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.82.3.677 contributor: fullname: Ikawa, Y – volume: 70 start-page: 2178 year: 1996 end-page: 2183 ident: B28 article-title: The prevalence of proviral bovine leukemia virus in peripheral blood mononuclear cells at two subclinical stages of infection publication-title: J Virol doi: 10.1128/JVI.70.4.2178-2183.1996 contributor: fullname: Lewin, HA – volume: 4 start-page: 837 year: 2020 end-page: 850 ident: B65 article-title: Enhanced immunotherapeutic efficacy of anti-PD-L1 antibody in combination with an EP4 antagonist publication-title: Immunohorizons doi: 10.4049/immunohorizons.2000089 contributor: fullname: Ohashi, K – volume: 7 start-page: 12 year: 2020 ident: B55 article-title: Upregulation of PD-L1 expression by prostaglandin E2 and the enhancement of IFN-γ by anti-PD-L1 antibody combined with a COX-2 inhibitor in Mycoplasma bovis infection publication-title: Front Vet Sci doi: 10.3389/fvets.2020.00012 contributor: fullname: Ohashi, K – volume: 94 start-page: 283 year: 2003 end-page: 294 ident: B34 article-title: The rapid quantitative analysis of bovine cytokine genes by real-time RT-PCR publication-title: Vet Microbiol doi: 10.1016/s0378-1135(03)00119-6 contributor: fullname: Onuma, M – volume: 122 start-page: 2395 year: 2012 end-page: 2404 ident: B58 article-title: Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs publication-title: J Clin Invest doi: 10.1172/JCI45138 contributor: fullname: Strom, TB – volume: 2 year: 2013 ident: B59 article-title: TIM3+FOXP3+ regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer publication-title: Oncoimmunology doi: 10.4161/onci.23849 contributor: fullname: Anderson, AC – volume: 144 start-page: 462 year: 2011 end-page: 467 ident: B43 article-title: Molecular cloning of bovine lymphocyte activation gene-3 and its expression characteristics in bovine leukemia virus-infected cattle publication-title: Vet Immunol Immunopathol doi: 10.1016/j.vetimm.2011.08.018 contributor: fullname: Ohashi, K – volume: 15 start-page: 380 year: 2019 ident: B47 article-title: Immune inhibitory function of bovine CTLA-4 and the effects of its blockade in IFN-γ production publication-title: BMC Vet Res doi: 10.1186/s12917-019-2082-7 contributor: fullname: Ohashi, K – volume: 15 start-page: 45 year: 2015 end-page: 56 ident: B2 article-title: Clinical blockade of PD1 and LAG3 — potential mechanisms of action publication-title: Nat Rev Immunol doi: 10.1038/nri3790 contributor: fullname: Ohashi, PS – volume: 16 start-page: 1622 year: 2018 end-page: 1626 ident: B17 article-title: Effect of CEACAM-1 knockdown in human colorectal cancer cells publication-title: Oncol Lett doi: 10.3892/ol.2018.8835 contributor: fullname: Sun, YW – volume: 366 start-page: 2443 year: 2012 end-page: 2454 ident: B60 article-title: Safety, activity, and immune correlates of anti-PD-1 antibody in cancer publication-title: N Engl J Med doi: 10.1056/NEJMoa1200690 contributor: fullname: Sznol, M – volume: 72 start-page: 6917 year: 1998 end-page: 6921 ident: B33 article-title: Interleukin-12 p40 mRNA expression in bovine leukemia virus-infected animals: increase in alymphocytosis but decrease in persistent lymphocytosis publication-title: J Virol doi: 10.1128/JVI.72.8.6917-6921.1998 contributor: fullname: Splitter, GA – volume: 12 year: 2017 ident: B40 article-title: In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) rat-bovine chimeric antibody against bovine leukemia virus infection publication-title: PLoS One doi: 10.1371/journal.pone.0174916 contributor: fullname: Ohashi, K – volume: 4 start-page: 1093 year: 2003 end-page: 1101 ident: B18 article-title: Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance publication-title: Nat Immunol doi: 10.1038/ni987 contributor: fullname: Strom, TB – volume: 107 start-page: 14733 year: 2010 end-page: 14738 ident: B19 article-title: Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1009731107 contributor: fullname: Ahmed, R – volume: 4 start-page: 18 year: 2007 ident: B31 article-title: Mechanisms of leukemogenesis induced by bovine leukemia virus: prospects for novel anti-retroviral therapies in human publication-title: Retrovirology doi: 10.1186/1742-4690-4-18 contributor: fullname: Willems, L – volume: 90 year: 2022 ident: B57 article-title: Prostaglandin E2-induced immune suppression via cytotoxic T-lymphocyte antigen 4 in paratuberculosis publication-title: Infect Immun doi: 10.1128/iai.00210-22 contributor: fullname: Ohashi, K – volume: 4 start-page: 1102 year: 2003 end-page: 1110 ident: B15 article-title: Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance publication-title: Nat Immunol doi: 10.1038/ni988 contributor: fullname: Kuchroo, VK – volume: 70 start-page: 5706 year: 1996 end-page: 5710 ident: B32 article-title: Increased interleukin-10 mRNA expression in tumor-bearing or persistently lymphocytotic animals infected with bovine leukemia virus publication-title: J Virol doi: 10.1128/JVI.70.8.5706-5710.1996 contributor: fullname: Splitter, GA – volume: 39 start-page: 2492 year: 2009 end-page: 2501 ident: B16 article-title: TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines publication-title: Eur J Immunol doi: 10.1002/eji.200939274 contributor: fullname: Kuchroo, VK – volume: 10 start-page: 29 year: 2009 end-page: 37 ident: B66 article-title: Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection publication-title: Nat Immunol doi: 10.1038/ni.1679 contributor: fullname: Wherry, EJ – volume: 83 start-page: 162 year: 2021 end-page: 166 ident: B53 article-title: The enhancement of Th1 immune response by anti-PD-L1 antibody in cattle infected with Mycobacterium avium subsp. paratuberculosis publication-title: J Vet Med Sci doi: 10.1292/jvms.20-0590 contributor: fullname: Ohashi, K – volume: 35 start-page: 51 year: 2014 end-page: 60 ident: B3 article-title: Tolerance and exhaustion: defining mechanisms of T cell dysfunction publication-title: Trends Immunol doi: 10.1016/j.it.2013.10.001 contributor: fullname: Greenberg, PD – volume: 18 start-page: 1394 year: 2012 end-page: 1400 ident: B13 article-title: Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion publication-title: Nat Med doi: 10.1038/nm.2871 contributor: fullname: Kuchroo, VK – volume: 86 year: 2018 ident: B52 article-title: Prostaglandin E2 induction suppresses the Th1 immune responses in cattle with Johne’s disease publication-title: Infect Immun doi: 10.1128/IAI.00910-17 contributor: fullname: Ohashi, K – volume: 34 start-page: 561 year: 2016 end-page: 567 ident: B25 article-title: Tim-3 expression represents dysfunctional tumor infiltrating T cells in renal cell carcinoma publication-title: World J Urol doi: 10.1007/s00345-015-1656-7 contributor: fullname: Sun, Y – volume: 54 start-page: 291 year: 2010 end-page: 298 ident: B36 article-title: Molecular cloning and expression analysis of bovine programmed death-1 publication-title: Microbiol Immunol doi: 10.1111/j.1348-0421.2010.00208.x contributor: fullname: Ohashi, K – volume: 369 start-page: 134 year: 2013 end-page: 144 ident: B61 article-title: Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma publication-title: N Engl J Med doi: 10.1056/NEJMoa1305133 contributor: fullname: Ribas, A – volume: 3 start-page: 454 year: 2003 end-page: 462 ident: B8 article-title: The TIM gene family: emerging roles in immunity and disease publication-title: Nat Rev Immunol doi: 10.1038/nri1111 contributor: fullname: Freeman, GJ – volume: 5 year: 2011 ident: B50 article-title: HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications publication-title: PLoS Negl Trop Dis doi: 10.1371/journal.pntd.0001030 contributor: fullname: Kallas, EG – volume: 26 start-page: 311 year: 2007 end-page: 321 ident: B10 article-title: T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand binding surface publication-title: Immunity doi: 10.1016/j.immuni.2007.01.016 contributor: fullname: Almo, SC – volume: 83 start-page: 9122 year: 2009 end-page: 9130 ident: B20 article-title: Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells publication-title: J Virol doi: 10.1128/JVI.00639-09 contributor: fullname: Rosen, HR – volume: 17 start-page: 165 year: 2019 ident: B64 article-title: TNF-α-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer publication-title: J Transl Med doi: 10.1186/s12967-019-1917-0 contributor: fullname: Huang, L – volume: 205 start-page: 2763 year: 2008 end-page: 2779 ident: B5 article-title: Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection publication-title: J Exp Med doi: 10.1084/jem.20081398 contributor: fullname: Ostrowski, MA – volume: 13 start-page: 832 year: 2012 end-page: 842 ident: B11 article-title: Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 publication-title: Nat Immunol doi: 10.1038/ni.2376 contributor: fullname: Jinushi, M – volume: 42 start-page: 103 year: 2011 ident: B37 article-title: Increase of cells expressing PD-L1 in bovine leukemia virus infection and enhancement of anti-viral immune responses in vitro via PD-L1 blockade publication-title: Vet Res doi: 10.1186/1297-9716-42-103 contributor: fullname: Ohashi, K – volume: 207 start-page: 2187 year: 2010 end-page: 2194 ident: B24 article-title: Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity publication-title: J Exp Med doi: 10.1084/jem.20100643 contributor: fullname: Anderson, AC – volume: 415 start-page: 536 year: 2002 end-page: 541 ident: B4 article-title: Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease publication-title: Nature doi: 10.1038/415536a contributor: fullname: Kuchroo, VK – volume: 207 start-page: 2175 year: 2010 end-page: 2186 ident: B23 article-title: Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients publication-title: J Exp Med doi: 10.1084/jem.20100637 contributor: fullname: Zarour, HM – volume: 4 start-page: 52 year: 2016 end-page: 63 ident: B35 article-title: Bovine leukemia virus reduces anti-viral cytokine activities and NK cytotoxicity by inducing TGF-β secretion from regulatory T cells publication-title: Immun Inflamm Dis doi: 10.1002/iid3.93 contributor: fullname: Ohashi, K – volume: 6 start-page: 1245 year: 2005 end-page: 1252 ident: B9 article-title: The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity publication-title: Nat Immunol doi: 10.1038/ni1271 contributor: fullname: Kuchroo, VK – volume: 517 start-page: 386 year: 2015 end-page: 390 ident: B12 article-title: CEACAM1 regulates TIM-3-mediated tolerance and exhaustion publication-title: Nature doi: 10.1038/nature13848 contributor: fullname: Blumberg, RS – volume: 49 start-page: 50 year: 2018 ident: B45 article-title: Cooperation of PD-1 and LAG-3 in the exhaustion of CD4+ and CD8+ T cells during bovine leukemia virus infection publication-title: Vet Res doi: 10.1186/s13567-018-0543-9 contributor: fullname: Ohashi, K – volume: 7 start-page: 10501 year: 2016 ident: B62 article-title: Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints publication-title: Nat Commun doi: 10.1038/ncomms10501 contributor: fullname: Hammerman, PS – volume: 25 start-page: 521 year: 1994 end-page: 536 ident: B29 article-title: Pathobiology of bovine leukemia virus publication-title: Vet Res contributor: fullname: Levy, D – volume: 44 start-page: 59 year: 2013 ident: B38 article-title: Blockade of bovine PD-1 increases T cell function and inhibits bovine leukemia virus expression in B cells in vitro publication-title: Vet Res doi: 10.1186/1297-9716-44-59 contributor: fullname: Ohashi, K – volume: 84 start-page: 2779 year: 2016 end-page: 2790 ident: B54 article-title: Cooperation of PD-1 and LAG-3 contributes to T-cell exhaustion in Anaplasma marginale-infected cattle publication-title: Infect Immun doi: 10.1128/IAI.00278-16 contributor: fullname: Brown, WC – volume: 6 year: 2017 ident: B63 article-title: Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer publication-title: Oncoimmunology doi: 10.1080/2162402X.2016.1261779 contributor: fullname: Ferris, RL – volume: 318 start-page: 1141 year: 2007 end-page: 1143 ident: B6 article-title: Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells publication-title: Science doi: 10.1126/science.1148536 contributor: fullname: Hafler, DA – volume: 43 start-page: 45 year: 2012 ident: B48 article-title: Increased bovine Tim-3 and its ligand expressions during bovine leukemia virus infection publication-title: Vet Res doi: 10.1186/1297-9716-43-45 contributor: fullname: Ohashi, K – volume: 68 start-page: 77 year: 2020 end-page: 90 ident: B56 article-title: Upregulation of PD-L1 expression by prostaglandin E2 and the enhancement of IFN-γ by anti-PD-L1 antibody combined with a COX-2 inhibitor in Mycoplasma bovis infection publication-title: Jpn J Vet Res doi: 10.14943/jjvr.68.2.77 contributor: fullname: Ohashi, K – ident: e_1_3_2_22_2 doi: 10.1172/JCI43127 – ident: e_1_3_2_14_2 doi: 10.1038/nm.2871 – ident: e_1_3_2_34_2 doi: 10.1128/JVI.72.8.6917-6921.1998 – ident: e_1_3_2_32_2 doi: 10.1186/1742-4690-4-18 – ident: e_1_3_2_18_2 doi: 10.3892/ol.2018.8835 – ident: e_1_3_2_10_2 doi: 10.1038/ni1271 – ident: e_1_3_2_35_2 doi: 10.1016/s0378-1135(03)00119-6 – ident: e_1_3_2_65_2 doi: 10.1186/s12967-019-1917-0 – ident: e_1_3_2_8_2 doi: 10.1016/j.jhep.2009.12.005 – ident: e_1_3_2_54_2 doi: 10.1292/jvms.20-0590 – ident: e_1_3_2_58_2 doi: 10.1128/iai.00210-22 – ident: e_1_3_2_13_2 doi: 10.1038/nature13848 – ident: e_1_3_2_66_2 doi: 10.4049/immunohorizons.2000089 – ident: e_1_3_2_42_2 doi: 10.3389/fimmu.2017.00650 – ident: e_1_3_2_21_2 doi: 10.1128/JVI.00639-09 – ident: e_1_3_2_31_2 doi: 10.1292/jvms.63.703 – ident: e_1_3_2_68_2 doi: 10.1016/j.dci.2020.103847 – ident: e_1_3_2_43_2 doi: 10.4049/jimmunol.1900342 – ident: e_1_3_2_52_2 doi: 10.1128/IAI.01014-15 – ident: e_1_3_2_26_2 doi: 10.1007/s00345-015-1656-7 – ident: e_1_3_2_15_2 doi: 10.1038/s41577-019-0224-6 – ident: e_1_3_2_37_2 doi: 10.1111/j.1348-0421.2010.00208.x – ident: e_1_3_2_53_2 doi: 10.1128/IAI.00910-17 – ident: e_1_3_2_2_2 doi: 10.1038/ni.2035 – ident: e_1_3_2_5_2 doi: 10.1038/415536a – ident: e_1_3_2_59_2 doi: 10.1172/JCI45138 – ident: e_1_3_2_44_2 doi: 10.1016/j.vetimm.2011.08.018 – ident: e_1_3_2_48_2 doi: 10.1186/s12917-019-2082-7 – ident: e_1_3_2_19_2 doi: 10.1038/ni987 – ident: e_1_3_2_55_2 doi: 10.1128/IAI.00278-16 – ident: e_1_3_2_3_2 doi: 10.1038/nri3790 – ident: e_1_3_2_40_2 doi: 10.1292/jvms.16-0354 – ident: e_1_3_2_45_2 doi: 10.1016/j.cimid.2012.09.005 – ident: e_1_3_2_36_2 doi: 10.1002/iid3.93 – ident: e_1_3_2_56_2 doi: 10.3389/fvets.2020.00012 – ident: e_1_3_2_17_2 doi: 10.1002/eji.200939274 – ident: e_1_3_2_50_2 doi: 10.1093/infdis/jiq153 – ident: e_1_3_2_29_2 doi: 10.1128/JVI.70.4.2178-2183.1996 – ident: e_1_3_2_27_2 doi: 10.1073/pnas.82.3.677 – ident: e_1_3_2_28_2 doi: 10.1128/JVI.68.7.4589-4596.1994 – ident: e_1_3_2_51_2 doi: 10.1371/journal.pntd.0001030 – ident: e_1_3_2_12_2 doi: 10.1038/ni.2376 – ident: e_1_3_2_49_2 doi: 10.1186/1297-9716-43-45 – ident: e_1_3_2_16_2 doi: 10.1038/ni988 – ident: e_1_3_2_41_2 doi: 10.1371/journal.pone.0174916 – ident: e_1_3_2_46_2 doi: 10.1186/s13567-018-0543-9 – ident: e_1_3_2_62_2 doi: 10.1056/NEJMoa1305133 – ident: e_1_3_2_4_2 doi: 10.1016/j.it.2013.10.001 – ident: e_1_3_2_63_2 doi: 10.1038/ncomms10501 – ident: e_1_3_2_7_2 doi: 10.1126/science.1148536 – ident: e_1_3_2_11_2 doi: 10.1016/j.immuni.2007.01.016 – ident: e_1_3_2_9_2 doi: 10.1038/nri1111 – ident: e_1_3_2_39_2 doi: 10.1186/1297-9716-44-59 – ident: e_1_3_2_24_2 doi: 10.1084/jem.20100637 – ident: e_1_3_2_20_2 doi: 10.1073/pnas.1009731107 – ident: e_1_3_2_67_2 doi: 10.1038/ni.1679 – ident: e_1_3_2_6_2 doi: 10.1084/jem.20081398 – ident: e_1_3_2_64_2 doi: 10.1080/2162402X.2016.1261779 – ident: e_1_3_2_61_2 doi: 10.1056/NEJMoa1200690 – ident: e_1_3_2_60_2 doi: 10.4161/onci.23849 – ident: e_1_3_2_33_2 doi: 10.1128/JVI.70.8.5706-5710.1996 – ident: e_1_3_2_38_2 doi: 10.1186/1297-9716-42-103 – ident: e_1_3_2_47_2 doi: 10.1016/j.vetimm.2014.10.006 – ident: e_1_3_2_57_2 doi: 10.14943/jjvr.68.2.77 – ident: e_1_3_2_23_2 doi: 10.1371/journal.pone.0009504 – volume: 25 start-page: 521 year: 1994 ident: e_1_3_2_30_2 article-title: Pathobiology of bovine leukemia virus publication-title: Vet Res contributor: fullname: Schwartz I – ident: e_1_3_2_25_2 doi: 10.1084/jem.20100643 |
| SSID | ssj0014464 |
| Score | 2.487449 |
| Snippet | Bovine leukemia virus (BLV) is a retrovirus that causes enzootic bovine leukosis (EBL) in cattle and is widespread in many countries, including Japan. Recent... Enzootic bovine leukosis caused by bovine leukemia virus (BLV) is an important viral disease in cattle, causing severe economic losses to the cattle industry... |
| SourceID | pubmedcentral crossref asm2 pubmed |
| SourceType | Open Access Repository Aggregation Database Index Database |
| StartPage | e0143022 |
| SubjectTerms | Animals Cattle CD8-Positive T-Lymphocytes - immunology Enzootic Bovine Leukosis - immunology Gene Expression Regulation - immunology Immune Checkpoint Proteins - immunology Immunology Interferon-gamma - immunology Leukemia Virus, Bovine - immunology Mucins - immunology Pathogenesis and Immunity Programmed Cell Death 1 Receptor - immunology |
| Title | Combined Immune Checkpoint Blockade Enhances Antiviral Immunity against Bovine Leukemia Virus |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/36598199 https://journals.asm.org/doi/10.1128/jvi.01430-22 https://pubmed.ncbi.nlm.nih.gov/PMC9888214 |
| Volume | 97 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9tAEF5qQ6GX0qQvt2lYSnuUba20r2PiOiT0QaEPciliH6NYcayYyC7033d2JZn40EvPGrFidpb5vtXMN4S8UwKkZZlNVJlxJChcJzpP84Q5yXgpp8rErrTzb_LLpfowDzI5vO-FiUX7zlbj-mY1rqtFrK1cr9ykrxObfP0800jbWJpPBmSA2LCn6N2vA-Q3eS8Rjqf5sq92Z2py_bsaBz27acLCFJtMcK2i6uvQNCu2l5l26Wi_VPJe7jl7Qh53oJGetB93QB5AfUgetmMk_zwlv_BQI8EFTy9CtwfQ2QLccn1b1Rt6islqaTzQeb0IG9zQkzoMjMBVWmtE4dRcmQphIj0N1wtAP8F2CavK0J_V3bZ5Rn6czb_PzpNubEJiOFObxClhpbBKOBDTMsu8sOAF0hrMS9pwJ0pnuJXWOq200Bp0qZhmPoIZsNPsORnWtzW8JNSG8-pSAzL1uU7BWJ5ary2CFmd9LkfkbfBc0cV9U0RKwVSBni6ipwvGRuR979di3Upo_MPuRevrnVW_QSMi93ZhZxC0sfefYMhEjewuRF7995uvyaMwWT7ctmTpERlu7rbwhgwavz1G5H3x8ThG3V_q5dp8 |
| link.rule.ids | 230,315,729,782,786,887,27934,27935,53802,53804 |
| linkProvider | National Library of Medicine |
| linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF7RIASXUh6FFFpWCI5O7LX3dWxDqlRNKyQK6gVZ-xgTE-JGdVKp_57dtR2RA5eedyyt_O145lvPfIPQJ8GAa5LqSBQpdQSFykhmSRYRwwkteCxU6EqbfOOX1-LL2Mvk0K4XJhTtG10Oqj-LQVXOQm3lcmGGXZ3Y8OvFSDraRpJsuIMeO3-NSUfS258HjuFknUi4W7_u6t2JGP6-Kwde0S6OiJ9jkzIqRdB97al6QbZi0yYgbRdL_hN9Tp8_cN97aLdNN_Fxs_wCPYLqJXrSDKC8f4V-us-Bo8Zg8ZnvEwE8moGZL2_KaoVPXJibKwt4XM380ajxceVHTbjdNdYuf8fqlypdgolP_MUE4Cms57AoFf5R3q7r1-j76fhqNInagQuRokSsIiOY5kwLZoDFRZpapsEyR4hcRJOKGlYYRTXX2kghmZQgC0EksSENAh2n-6hX3VTwFmHtPd0kCnhiM5mA0jTRVmqX7hhtM95HH_0bz1uPqfNARojIHUJ5QCgnpI8-d3jky0Z84z92bxqMNlYdsH3Et9DbGHhV7e0VB1pQ125BOnjwkx_Q08nVxTSfnl2ev0PP_Hx6f2eTJu9Rb3W7hkO0U9v1UTizfwEYpu8V |
| linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bT9swFLZGp017AXYBOmCzpu0xTeIkvjxCaQUaQ0i7iJcp8uWEZqWhIi3S_j22k1T0gZft2SeSlc_OOZ9z_H0IfeYUmCKJCniRZJagZCIQaZwGRDOSFSzi0t9KO_3OLq74ycjJ5KysvnzTvlbloLqZDapy4nsr5zMddn1i4eW3obC0jcRpODdFuIGe2z0bpR1Rb38gWJaTdkLhdvyq63knPPxzXw6cql0UEOdlk9BMcK_92pP1jKzlp1VSWm-YfJSBxlv_MfdttNmWnfioCXmNnkH1Br1ojCj_vkW_7WfBUmQw-MzdFwE8nICezm_LaoGPbbqbSgN4VE3cEqnxUeUsJ-wMm2hbx2N5LUtbaOJjd0AB-ByWU5iVEv8q75b1O_RzPPoxPA1a44VAZoQvAs2pYlRxqoFGRZIYqsBQS4xsZhMy07TQMlNMKS24oEKAKDgRxPhyCFSU7KBedVvBHsLK7XgdS2CxSUUMUmWxMkLZskcrk7I--uTeet7unDr3pITw3KKUe5RyQvroS4dJPm9EOJ6I221wWkV14PYRW0NwFeDUtddHLHBeZbsF6v0_P_kRvbw8GefnZxdf99ErZ1Pvjm6S-AD1FndLOEQbtVl-8Mv2AbAL8ZU |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Combined+Immune+Checkpoint+Blockade+Enhances+Antiviral+Immunity+against+Bovine+Leukemia+Virus&rft.jtitle=Journal+of+virology&rft.au=Nakamura%2C+Hayato&rft.au=Konnai%2C+Satoru&rft.au=Okagawa%2C+Tomohiro&rft.au=Maekawa%2C+Naoya&rft.date=2023-01-31&rft.pub=American+Society+for+Microbiology&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=97&rft.issue=1&rft_id=info:doi/10.1128%2Fjvi.01430-22&rft_id=info%3Apmid%2F36598199&rft.externalDBID=PMC9888214 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon |